Quote & Headlines
Market Currents
StockTalk
Today
5d
1m
3m
1y
5y
10y
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
26,085 people get JNJ articles and Market Currents by email alert.
Get email alerts on JNJ »
HEADLINES:
ALL
|
PRO
|
FOCUS
|
RELATED
|
TRANSCRIPTS
|
NEWS & PR
To learn more about Seeking Alpha Pro, click here.
-
Johnson & Johnson's CEO Hosts Annual Meeting of Shareholders (Transcript)Thu, Apr 26, 2012 • 1 Comment
-
Johnson & Johnson Services, Inc. Q2 2010 Earnings Call TranscriptTue, Jul 20, 2010
-
Johnson & Johnson Q1 2010 Earnings Call TranscriptTue, Apr 20, 2010
-
Johnson & Johnson Q4 2009 Earnings Call TranscriptTue, Jan 26, 2010
-
Johnson & Johnson Q3 2009 Earnings Call TranscriptTue, Oct 13, 2009
-
Johnson & Johnson Q2 2009 Earnings Call TranscriptTue, Jul 14, 2009
-
Johnson & Johnson F1Q09 (Qtr End 03/29/09) Earnings Call TranscriptTue, Apr 14, 2009 • 1 Comment
-
Johnson & Johnson Q4 2008 Earnings Call TranscriptTue, Jan 20, 2009
-
at CNBC.com (Tue, 4:06PM)
-
at MarketWatch.com (Tue, 8:46AM)
-
at MarketWatch.com (Sun, 12:18PM)
-
at MarketWatch.com (May 3, 2013)
-
at CNBC.com (May 1, 2013)
-
at MarketWatch.com (May 1, 2013)
-
at CNBC.com (Apr 30, 2013)
-
at CNBC.com (Apr 29, 2013)
-
at CNBC.com (Apr 26, 2013)
-
at CNBC.com (Apr 25, 2013)
-
PR Newswire (Apr 25, 2013)
-
PR Newswire (Apr 23, 2013)
-
at CNBC.com (Apr 23, 2013)
-
at CNBC.com (Apr 22, 2013)
-
at CNBC.com (Apr 22, 2013)
-
at CNBC.com (Apr 22, 2013)
-
at Fox Business (Apr 19, 2013)
-
PR Newswire (Apr 18, 2013)
-
at CNBC.com (Apr 17, 2013)
JNJ vs. ETF Alternatives
Company Description
General
Johnson & Johnson and its subsidiaries have approximately 115,500 employees worldwide engaged in the research and development, manufacture and sale of a broad range of products in the health care field. Johnson & Johnson is a holding company, which has more than 250 operating... More
- All
- | Earnings
- | Dividends
- | M&A
- | On the move
- Tuesday, April 16, 7:52 AM Johnson & Johnson (JNJ): Q1 EPS of $1.44 beats by $0.04. Revenue of $17.5B (+8.5% Y/Y) beats by $0.04B. (PR) Comment! [Earnings, Breaking News, Healthcare]
- Tuesday, April 16, 12:05 AM Notable earnings before Tuesday’s open: AMTD, BLK, CMA, GS, GWW, JNJ, KO, NTRS, USB, WWW Comment! [Earnings]
- Monday, April 15, 5:30 PM Notable earnings before Tuesday’s open: AMTD, BLK, CMA, GS, GWW, JNJ, KO, NTRS, USB, WWW Comment! [Earnings]
- Tuesday, January 22, 8:03 AM More on Johnson & Johnson (JNJ) Q4: net profit excluding special items +7.9% to $3.4B; those items amount to $800M, and include "litigation accrual" and program costs associated with DePuy's recalled artificial hip. Acquisition of Synthes contributes 5.6% to sales growth. Domestic revenues +6.8%, international +8.9%. Shares -0.9%. (PR) Comment! [Earnings, Healthcare]
- Tuesday, January 22, 7:47 AM Johnson & Johnson (JNJ): Q4 EPS of $1.19 beats by $0.02. Revenue of $17.6B (+8% Y/Y) misses by $0.07B. Shares -1.3% premarket. (PR) Comment! [Earnings, Breaking News, Healthcare, On the Move]
- Tuesday, January 22, 12:04 AM Notable earnings before Tuesday’s open: AMTD, CNI, CRBC, DAL, DD, EAT, FCX, FMER, JNJ, KSU, MTG, PETS, RF, SNV, TRV, VZ, WAT Comment! [Earnings]
- Tuesday, October 16, 2012, 8:01 AM More on Johnson & Johnson (JNJ): Pharmaceutical sales in the U.S. rose 14.6% Y/Y to $3.288B. On a regional basis, gains in the Western Hemisphere and Asia-Pacific Africa helped to offset a 3.4% decline of revenue in Europe. Sees full-year 2012 EPS of $5.05-$5.10, lower than prior guidance of $5.00-$5.07 and the consensus mark of analysts calling for $5.06. Shares +1.2% premarket. (PR) 4 Comments [Consumer, Earnings]
- Tuesday, October 16, 2012, 7:49 AM Johnson & Johnson (JNJ): Q3 EPS of $1.25 beats by $0.04. Revenue of $17.1B (+6.5% Y/Y) beats by $150M. (PR) Comment! [Earnings, Healthcare]
- Tuesday, October 16, 2012, 12:05 AM Notable earnings before Tuesday’s open: DPZ, FRX, GS, GWW, IRWD, JNJ, KO, MAT, OMC, PNC, STT, UNH Comment! [Earnings]
- Monday, October 15, 2012, 5:30 PM Notable earnings before Tuesday’s open: DPZ, FRX, GS, GWW, IRWD, JNJ, KO, MAT, OMC, PNC, STT, UNH Comment! [Earnings]
- Tuesday, July 17, 2012, 11:09 AM SA author Stephen Simpson says J&J (JNJ -0.7%) had a decent Q2, with an encouraging underlying performance in the company's drug and orthopedics ops. Simpson's main concern is the devices and diagnostics arms, the latter seeming to be slipping "further and further behind." Still, J&J "looks like a worthwhile name for conservative investors looking for healthcare exposure." Comment! [Healthcare, Earnings]
- Tuesday, July 17, 2012, 8:12 AM More on J&J's (JNJ) Q2: Net profit falls to $1.41B from $2.78B; Q2 2012 includes special items of $2.2B, comprising a write-down related to J&J's Crucell (CRXL) vaccine ops, provision for litigation, costs connected to Synthes acquisition. Cuts 2012 EPS outlook to $5.00-$5.07 from up to $5.17. Consensus is $5.14. Shares -1.4%. (PR) Comment! [Earnings, Top Stories, Healthcare]
- Tuesday, July 17, 2012, 7:55 AM Johnson & Johnson (JNJ): Q2 EPS of $1.30 beats by $0.01. Revenue of $16.5B (-0.7% Y/Y) misses by $200M. Shares -1.2% premarket. (PR) Comment! [Earnings]
- Tuesday, July 17, 2012, 12:05 AM Notable earnings before Tuesday's open: AMTD, CMA, EDU, FRX, GS, HST, JNJ, KO, KSU,MAT, MMR, MOS, MTB, OMC, SCHW, STT Comment! [Earnings]
- Monday, July 16, 2012, 5:30 PM Notable earnings before Tuesday's open: AMTD, CMA, EDU, FRX, GS, HIST, JNJ, KO, KSU,MAT, MMR, MOS, MTB, OMC, SCHW, STT Comment! [Earnings]
- Tuesday, April 17, 2012, 8:12 AM More on Johnson & Johnson's (JNJ) Q1: Worldwide Consumer sales -2.4% Y/Y to $3.6B, hurt by negative currency impact of 2.9%. Worldwide pharmaceutical sales +1.2% to $6.1B, led by strong international sales of Remicade. Worldwide Medical Devices and Diagnostics sales -0.3% to $6.4B. Sees FY12 EPS of $5.07-$5.17, above prior guidance of $5.05-$5.15. Shares +0.5% premarket. (PR) 1 Comment [Earnings, On the Move]
-
- View all 0 replies
-
- View all 0 replies
-
Alan Brochstein
Sold $JNJ in Conservative Growth/Balanced on Monday - had held since July 2008 but it is due for consolidation and likely a pullback - View all 0 replies
-
- View all 0 replies
-
CarefulInvesting
Donot use $JNJ Products. Check this out. Apparently carciogenic was used in some baby products:- http://bit.ly/16u0y6b - View all 0 replies
-
- View all 0 replies
-
Dividend Sheet
$SDR $MEMP and $BBEP are the best yielding stocks with recent dividend hikes - http://stks.co/jT59 - 89 shares with 4.02% Yield $JNJ $WFC - View all 0 replies
-
- View all 0 replies
-
- View all 0 replies
-
Casey Hoerth
Big news of the day for dividend investors? $JNJ grew its revenues 8% YoY. This bodes very well for us... - View all 0 replies
LATEST REPLIES
-
- View all 7 replies
-
Ocean Man: If CAT dips next Monday into the 70s, that could be interesting. -
-
- View all 5 replies
-
-
bdy: yep I lost money but I think I made a decent assumption on the trade so I'm okay with the small loss
-
O. Young Kwon
TANER Stock Model (TSM) Momentum 4/11/2013 (Thursday): (1-2-3) Home Depot ($HD) Johnson & Johnson ($JNJ) Nu Skin ($NUS) <c> - View all 2 replies
-
-
O. Young Kwon: (The numbers are terms in months.) For The TANER System and its four Models, read my article. Link:http://seekingalpha.com/a/hitr yk
-
neobliviscar
Time for a Rant- $JNJ up more in past year than previous 10 years combined. Grocery chains up +20 to +30% in Q1. $BBY flying high! - View all 2 replies
-
neobliviscar: Put on Grumpy Old Men hat today. Lots o people's 2013 targets already hit, and its only April. Irrational greed approaching idiotic...
-
cyrus trask: just keep raising the price targets. The path of least resistance still points up.
-
- View all 3 replies
-
-
O. Young Kwon: (The numbers are terms in months.) For The TANER System and its four Models, read my article. Link:http://seekingalpha.com/a/hitr yk
-
- View all 3 replies
-
-
O. Young Kwon: (The numbers are terms in months.) For The TANER System and its four Models, read my article. Link:http://seekingalpha.com/a/hitr yk
-
- View all 3 replies
-
-
O. Young Kwon: (The numbers are terms in months.) For The TANER System and its four Models, read my article. Link:http://seekingalpha.com/a/hitr yk
-
O. Young Kwon
TANER Stock Model (TSM) Momentum 3/6/2013 (Wednesday): (1-2-3) <$JNJ $KSU $SU> Johnson & Johnson ($JNJ) <c> - View all 3 replies
-
-
O. Young Kwon: (The numbers are terms in months.) For The TANER System and its four Models, read my article. Link:http://seekingalpha.com/a/hitr yk
-
O. Young Kwon
TANER Stock Model [TSM] Momentum 2/21/2013 (Thursday): (1-2-3) Johnson & Johnson ($JNJ) Perrigo ($PRGO) <c> - View all 2 replies
-
-
O. Young Kwon: (The numbers are terms in months.) For The TANER System and its four Models, read my article. Link:http://seekingalpha.com/a/hitr yk
-
Dividend Sheet
$BX $GSK and $TOT are the best yielding and most bought dividend stocks from investment gurus + http://stks.co/bKV1 + I like $INTC and $JNJ - View all 1 replies
-
-
O. Young Kwon
TANER Stock Model [TSM] Momentum 2/11/2013 (Monday): (1-2-3) <$JNJ $CME $EDU)> Johnson & Johnson ($JNJ) <c> - View all 3 replies
-
-
O. Young Kwon: (The numbers are terms in months.) For The TANER System and its four Models, read my article. Link:http://seekingalpha.com/a/hitr yk
-
O. Young Kwon
TANER Stock Model [TSM] Momentum 2/11/2013 (Monday): (1-2-3) Johnson & Johnson ($JNJ) Oriental Education & Tech ($EDU) <c> - View all 2 replies
-
-
O. Young Kwon: (The numbers are terms in months.) For The TANER System and its four Models, read my article. Link:http://seekingalpha.com/a/hitr yk
-
arudnicki415
Not a big believe in the media doom and gloom, but seeing $JNJ and $BA near 52 wk highs despite product recalls makes one wonder - View all 1 replies
-
HackFab: Boeing is an anomoly, I've owned it for several years, and it consistantly acts inversely to any news. Good=Down, Bad=Up. ????
-
O. Young Kwon
TANER Stock Model [TSM] Momentum 1/25/2013 (Friday): (1-2-3) <c> <$JNJ $IBM $EDU> Johnson & Johnson ($JNJ) <c> - View all 3 replies
-
-
O. Young Kwon: (The numbers are terms in months.) For The TANER System and its four Models, read my article. Link:http://seekingalpha.com/a/hitr yk
-
O. Young Kwon
TANER Stock Model [TSM] Momentum 1/23/2013 (Wednesday): (2-3) ) <$JNJ $KSU> Johnson & Johnson ($JNJ) <c> - View all 3 replies
-
-
O. Young Kwon: (The numbers are terms in months.) For The TANER System and its four Models, read my article. Link:http://seekingalpha.com/a/hitr yk